Proton pump inhibitors and gastric cancer: association is not causation
Gut
.
2019 Aug;68(8):1529-1530.
doi: 10.1136/gutjnl-2018-316958.
Epub 2018 Jul 13.
Authors
Paul Moayyedi
1
,
Sander J O Veldhuyzen van Zanten
2
,
Lawrence Hookey
3
,
David Armstrong
1
,
Nicola Jones
4
5
6
,
Grigorios I Leontiadis
1
Affiliations
1
Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
2
Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.
3
Division of Gastroenterology, Queen's University, Kingston, Ontario, Canada.
4
Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
5
Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
6
Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
PMID:
30006494
DOI:
10.1136/gutjnl-2018-316958
No abstract available
Keywords:
epidemiology; gastric adenocarcinoma; proton pump inhibition.
Publication types
Letter
Comment
MeSH terms
Anti-Ulcer Agents*
Helicobacter pylori*
Humans
Proton Pump Inhibitors
Stomach Neoplasms*
Substances
Anti-Ulcer Agents
Proton Pump Inhibitors